RSS 1.0Rheumatology
Recent Submissions
-
Analgesic efficacy of therapies used for complex regional pain syndrome: a systematic reviewAnalgesic efficacy of therapies used for complex regional pain syndrome: a systematic review
-
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel of healthcare professionals in the UKEnhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel of healthcare professionals in the UK
-
More than skin-deep: visceral fat is strongly associated with disease activity, function and metabolic indices in psoriatic disease.Objective: To compare body composition between patients with psoriatic disease (PsD), including cutaneous psoriasis (PsO) and psoriatic arthritis (PsA), and controls, and to explore associations between disease activity and measures of function and metabolic derangement.
-
Real-world evidence for secukinumab in UK patients with psoriatic arthritis or radiographic axial spondyloarthritis : interim 2-year analysis from SERENAThe safety set comprised 189 patients (PsA, n = 81; r-axSpA, n = 108), and the target population set comprised 183 patients (PsA, n = 78; r-axSpA, n = 105). In the safety set, 107 patients (45 of 81 with PsA and 62 of 108 with r-axSpA) had previously received a biologic agent. Retention rates were similar between patients with PsA and r-axSpA after 1 year (PsA 91.0%, 95% CI: 84.0, 98.0; r-axSpA 89.2%, 95% CI: 82.7, 95.7) and 2 years (PsA 77.6%, 95% CI: 67.6, 87.7; r-axSpA 76.2%, 95% CI: 67.4, 85.0) of observation. Overall, 17.5% of patients (33 of 189) experienced at least one treatment-related adverse event, and 12.7% of patients (24 of 189) discontinued secukinumab because of adverse events.
-
Points to consider: EULAR-UEMS standards for the training of European rheumatologists.Background: Postgraduate rheumatology training programmes are already established at a national level in most European countries. However, previous work has highlighted a substantial level of heterogeneity in the organisation and, in part, content of programmes. Objective: To define competences and standards of knowledge, skills and professional behaviours required for the training of rheumatologists.